Current research in immunology最新文献

{"title":"Short chain fatty acids (SCFAs) improves TNBS-induced colitis in zebrafish","authors":"Camila Morales Fénero PhD ,&nbsp;Mariana Abrantes Amaral ,&nbsp;Izabella Karina Xavier ,&nbsp;Barbara Nunes Padovani ,&nbsp;Lais Cavalieri Paredes Msc ,&nbsp;Tatiana Takiishi PhD ,&nbsp;Mônica Lopes-Ferreira PhD ,&nbsp;Carla Lima PhD ,&nbsp;Alicia Colombo PhD ,&nbsp;Niels Olsen Saraiva Câmara MD. PhD","doi":"10.1016/j.crimmu.2021.08.003","DOIUrl":"10.1016/j.crimmu.2021.08.003","url":null,"abstract":"<div><p>The short-chain fatty acids (SCFAs) are metabolites originated from the fermentation of dietary fibers and amino acids produced by the bacteria of the intestinal microbiota. The most abundant SCFAs, acetate, propionate, and butyrate, have been proposed as a treatment for inflammatory bowel diseases (IBDs) due to their anti-inflammatory properties. This work aimed to analyze the effects of the treatment of three combined SCFAs in TNBS-induced intestinal inflammation in zebrafish larvae. Here, we demonstrated that SCFAs significantly increased the survival of TNBS-exposed larvae, preserved the intestinal endocytic function, reduced the expression of inflammatory cytokines and the intestinal recruitment of neutrophils caused by TNBS. However, SCFAs treatment did not appear to avoid TNBS-induced tissue damage in the intestinal wall and did not restore the number of mucus-producing goblet cells. Finally, exposure to TNBS induced dysbiosis of the microbiota with an increase in Betaproteobacteria and Actinobacteria, while the treatment with SCFAs maintained these population levels similar to control. Thus, we demonstrate that the treatment of three combined SCFAs presented anti-inflammatory properties previously seen in mammals, opening an opportunity to use zebrafish to explore the potential benefit of these and other metabolites to treat inflammation.</p></div>","PeriodicalId":72750,"journal":{"name":"Current research in immunology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.crimmu.2021.08.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46451510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Functional role of the cancer microbiome in the solid tumour niche","authors":"Erin A. Marshall,&nbsp;Nikita Telkar,&nbsp;Wan L. Lam","doi":"10.1016/j.crimmu.2021.01.001","DOIUrl":"10.1016/j.crimmu.2021.01.001","url":null,"abstract":"<div><p>The importance of gut microbiome to cancer therapy and response cannot be overstated, however the contribution of the bacterial population to the local solid tumour ecosystem is often overlooked. Seminal studies of tumour-resident microbiomes have shown that relative abundances of specific bacteria in the tumour correlate with survival metrics, implicating the microbiome in patient outcome. Similarly, patterns of microbiome community shifts between tumour-bearing and unaffected organs suggests a role for the tumour microbiome niche in contributing to tumour biology and behaviour. Recent reports of the detection of bacteria in solid tumours of diverse human organs have provided a strong rationale for deciphering the role of the solid-tumour microbiome across all human-host anatomic and physiologic niches, as the microbiome is ubiquitously present throughout the human body. Here, we review the role of the human microbiome in mediating response to therapies, as well as the differences between tumour and non-malignant-resident communities. We discuss the ability of the tumour microbiome to interact with the host, thereby influencing host cell behaviour and cancer-associated processes. Further, we evaluate recent technological advances that allow us to actively quantify these populations and the relationships between cell types. Finally, we suggest how these dynamic interactions can be harnessed for therapeutic benefit in the treatment of cancer.</p></div>","PeriodicalId":72750,"journal":{"name":"Current research in immunology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.crimmu.2021.01.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45849962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Genetic changes of Plasmodium vivax tempers host tissue-specific responses in Anopheles stephensi","authors":"Seena Kumari ,&nbsp;Charu Chauhan ,&nbsp;Sanjay Tevatiya ,&nbsp;Deepak Singla ,&nbsp;Tanwee Das De ,&nbsp;Punita Sharma ,&nbsp;Tina Thomas ,&nbsp;Jyoti Rani ,&nbsp;Deepali Savargaonkar ,&nbsp;Kailash C. Pandey ,&nbsp;Veena Pande ,&nbsp;Rajnikant Dixit","doi":"10.1016/j.crimmu.2021.02.002","DOIUrl":"10.1016/j.crimmu.2021.02.002","url":null,"abstract":"<div><p>Recently, we showed how an early restriction of gut flora proliferation by <em>Plasmodium vivax</em> favors immune-suppression and <em>Plasmodium</em> survival in the gut lumen (Sharma et al., 2020). Here, we asked post gut invasion how <em>P. vivax</em> interacts with individual tissues such as the midgut, hemocyte, and salivary glands, and manages its survival in the mosquito host. Our data from tissue-specific comparative RNA-Seq analysis and extensive temporal/spatial expression profiling of selected mosquito transcripts in the uninfected and <em>P. vivax</em> infected mosquito’s tissues indicated that (i) a transient suppression of gut metabolic machinery by early oocysts; (ii) enriched expression of nutritional responsive proteins and immune proteins against late oocysts, together may ensure optimal parasite development and gut homeostasis restoration; (iii) pre-immune activation of hemocyte by early gut-oocysts infection <em>via</em> REL induction (p ​&lt; ​0.003); and altered expression of hemocyte-encoded immune proteins may cause rapid removal of free circulating sporozoites from hemolymph; (iv) while a strong suppression of salivary metabolic activities, and elevated expression of salivary specific secretory, as well as immune proteins together, may favor the long-term storage and survival of invaded sporozoites. Finally, our RNA-Seq-based discovery of 4449 transcripts of <em>Plasmodium vivax</em> origin, and their developmental stage-specific expression modulation in the corresponding infected mosquito tissues, predicts a possible mechanism of mosquito responses evasion by <em>P. vivax</em>. Conclusively, our system-wide RNA-Seq analysis provides the first genetic evidence of direct mosquito-<em>Plasmodium</em> interaction and establishes a functional correlation.</p></div>","PeriodicalId":72750,"journal":{"name":"Current research in immunology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.crimmu.2021.02.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47507664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Tumor-infiltrating T-regulatory cells adapt to altered metabolism to promote tumor-immune escape","authors":"Tania Sarkar,&nbsp;Subhanki Dhar,&nbsp;Gaurisankar Sa","doi":"10.1016/j.crimmu.2021.08.002","DOIUrl":"10.1016/j.crimmu.2021.08.002","url":null,"abstract":"<div><p>Tumor mass and its microenvironment alter host immune system in various ways to promote tumor growth. One of the modifications is evasion of immune surveillance by augmenting the number of Tregs in tumor vicinity. Elevated levels of Tregs are seen in peripheral circulation and tumor tissue of cancer patients. Cancer cells release several chemokines to attract Tregs in tumor-site. Infiltration of Tregs has clinical significance because being immunosuppressive infiltrating Tregs suppress other immune cells making the tumor microenvironment favorable for tumor growth. On the other hand, infiltrating Tregs show metabolic alteration in tumor microenvironment which allows their selective survival over the others. Persistence of Tregs in the tumor microenvironment and subsequent immunosuppression makes Tregs a potential therapeutic obstacle and the reason behind the failure of immunotherapy. In this review, we emphasize the recent development in the metabolic adaptation of tumor-infiltrating Tregs and the therapeutic approaches to boost immunity against cancer.</p></div>","PeriodicalId":72750,"journal":{"name":"Current research in immunology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.crimmu.2021.08.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43132351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of IgG1 N-glycosylation on their interaction with Fc gamma receptors","authors":"Florian Cambay ,&nbsp;Céline Raymond ,&nbsp;Denis Brochu ,&nbsp;Michel Gilbert ,&nbsp;The Minh Tu ,&nbsp;Christiane Cantin ,&nbsp;Anne Lenferink ,&nbsp;Maxime Grail ,&nbsp;Olivier Henry ,&nbsp;Gregory De Crescenzo ,&nbsp;Yves Durocher","doi":"10.1016/j.crimmu.2020.06.001","DOIUrl":"10.1016/j.crimmu.2020.06.001","url":null,"abstract":"<div><p>The effector functions of the IgGs are modulated by the N-glycosylation of their Fc region. Particularly, the absence of core fucosylation is known to increase the affinity of IgG1s for the Fcγ receptor IIIa expressed by immune cells, in turn translating in an improvement in the antibody-dependent cellular cytotoxicity. However, the impact of galactosylation and sialylation is still debated in the literature. In this study, we have investigated the influence of high and low levels of core fucosylation, terminal galactosylation and terminal α2,6-sialylation of the Fc N-glycans of trastuzumab on its affinity for the FcγRIIIa. A large panel of antibody glycoforms (i.e., highly α2,6-sialylated or galactosylated IgG1s, with high or low levels of core fucosylation) were generated and characterized, while their interactions with the FcγRs were analysed by a robust surface plasmon resonance-based assay as well as in a cell-based reporter bioassay. Overall, IgG1 glycoforms with reduced fucosylation display a stronger affinity for the FcγRIIIa. In addition, fucosylation, and the presence of terminal galactose and sialic acids are shown to increase the affinity for the FcγRIIIa as compared to the agalactosylated forms. These observations perfectly translate in the response observed in our reporter bioassay.</p></div>","PeriodicalId":72750,"journal":{"name":"Current research in immunology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.crimmu.2020.06.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48215805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Myeloid cell responsiveness to interferon-gamma is sufficient for initial resistance to Listeria monocytogenes","authors":"Emily M. Eshleman ,&nbsp;Nikki Bortell,&nbsp;Daniel S. McDermott ,&nbsp;William J. Crisler,&nbsp;Laurel L. Lenz","doi":"10.1016/j.crimmu.2020.01.001","DOIUrl":"10.1016/j.crimmu.2020.01.001","url":null,"abstract":"<div><p>The type II interferon (IFNγ) promotes resistance to intracellular pathogens. Most immune and somatic cells also express the IFNγ receptor (IFNGR) and respond to IFNγ. While myeloid cell have been implicated as important targets of IFNγ, it remains unknown if IFNγ signaling to myeloid cell types suffices for resistance to infection. Here, we addressed this question by generating mice in which IFNGR1 is selectively expressed by myeloid cells. These “<em>MSGR1</em>” (myeloid selective IFNGR1) mice express an epitope-tagged <em>Ifngr1</em> transgene (fGR1) from the myeloid-specific <em>c-fms</em> promoter in a background lacking endogenous <em>Ifngr1</em>. IFNGR staining was selectively observed on myeloid cells in the MSGR1 mice and correlated with responsiveness of these cells to IFNγ. During systemic infection by the bacterium <em>Listeria monocytogenes</em>, activation marker staining was comparable on monocytes from MSGR1 and control B6 mice. Bacterial burdens and survival were also equivalent in MSGR1 and wildtype B6 animals at a timepoint when B6.<em>Ifngr1</em>^−/− mice began to succumb. These data confirm that activation of inflammatory monocytes and neutrophils is a key mechanism by which IFNγ promotes innate anti-bacterial immunity and suggest that IFNγ targeting of myeloid cells is largely sufficient to mediate protection against systemic <em>L. monocytogenes</em>.</p></div>","PeriodicalId":72750,"journal":{"name":"Current research in immunology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.crimmu.2020.01.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39268108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Protein interactome of the Cancerous Inhibitor of protein phosphatase 2A (CIP2A) in Th17 cells","authors":"Mohd Moin Khan ,&nbsp;Tommi Välikangas ,&nbsp;Meraj Hasan Khan ,&nbsp;Robert Moulder ,&nbsp;Ubaid Ullah ,&nbsp;Santosh Dilip Bhosale ,&nbsp;Elina Komsi ,&nbsp;Umar Butt ,&nbsp;Xi Qiao ,&nbsp;Jukka Westermarck ,&nbsp;Laura L. Elo ,&nbsp;Riitta Lahesmaa","doi":"10.1016/j.crimmu.2020.02.001","DOIUrl":"10.1016/j.crimmu.2020.02.001","url":null,"abstract":"<div><p>Cancerous inhibitor of protein phosphatase 2A (CIP2A) is involved in immune response, cancer progression, and Alzheimer's disease. However, an understanding of the mechanistic basis of its function in this wide spectrum of physiological and pathological processes is limited due to its poorly characterized interaction networks. Here we present the first systematic characterization of the CIP2A interactome by affinity-purification mass spectrometry combined with validation by selected reaction monitoring targeted mass spectrometry (SRM-MS) analysis in T helper (Th) 17 (Th17) cells. In addition to the known regulatory subunits of protein phosphatase 2A (PP2A), the catalytic subunits of protein PP2A were found to be interacting with CIP2A. Furthermore, the regulatory (PPP1R18, and PPP1R12A) and catalytic (PPP1CA) subunits of phosphatase PP1 were identified among the top novel CIP2A interactors. Evaluation of the ontologies associated with the proteins in this interactome revealed that they were linked with RNA metabolic processing and splicing, protein traffic, cytoskeleton regulation and ubiquitin-mediated protein degradation processes. Taken together, this network of protein-protein interactions will be important for understanding and further exploring the biological processes and mechanisms regulated by CIP2A both in physiological and pathological conditions.</p></div>","PeriodicalId":72750,"journal":{"name":"Current research in immunology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.crimmu.2020.02.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25570948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Current research in immunology inaugural editorial","authors":"Jose A. Villadangos","doi":"10.1016/j.crimmu.2020.11.001","DOIUrl":"10.1016/j.crimmu.2020.11.001","url":null,"abstract":"","PeriodicalId":72750,"journal":{"name":"Current research in immunology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.crimmu.2020.11.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39040641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Protein interactome of the Cancerous Inhibitor of protein phosphatase 2A (CIP2A) in Th17 cells","authors":"Mohd Moin Khan, Tommi Välikangas, M. H. Khan, R. Moulder, Ubaid Ullah, S. D. Bhosale, Elina Komsi, Umar Butt, X. Qiao, J. Westermarck, L. Elo, R. Lahesmaa","doi":"10.1101/809459","DOIUrl":"https://doi.org/10.1101/809459","url":null,"abstract":"Cancerous inhibitor of protein phosphatase 2A (CIP2A) is involved in immune response, cancer progression, and in Alzheimer’s disease. However, an understanding of the mechanistic basis of its function in this wide spectrum of physiological and pathological processes is limited due to its poorly characterized interaction networks. Here we present the first systematic characterization of the CIP2A interactome by affinity-purification mass spectrometry combined with validation by selected reaction monitoring targeted mass spectrometry (SRM-MS) analysis in Th17 cells. In addition to the known regulatory subunit of protein phosphatase PP2A, the catalytic subunit of protein PP2A was found to be interacting with CIP2A. Furthermore, the regulatory (PPP1R18, and PPP1R12A) and catalytic (PPP1CA) subunits of phosphatase PP1 were identified among the top novel CIP2A interactors. Evaluation of the ontologies associated with the proteins in this interactome revealed that they were linked with RNA metabolic processing and splicing, protein traffic, cytoskeleton regulation and ubiquitin-mediated protein degradation processes. Taken together, this network of protein-protein interactions will be important for understanding and further exploring the biological processes and mechanisms regulated by CIP2A both in physiological and pathological conditions. Highlights ▪ The first characterisation of the CIP2A interactome in Th17 cells. ▪ Key interactions were validated by targeted SRM-MS proteomics, western blot and confocal microscopy. ▪ Pathway analysis of the interactome revealed interrelationships with proteins across a broad range of processes, in particular associated with mRNA processing.","PeriodicalId":72750,"journal":{"name":"Current research in immunology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48785108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}